Personalizing Augmentation Therapy for Treatment-Resistant Depression

Clinical guidance addresses how to select add-on medications for major depressive disorder based on individual patient characteristics and treatment response patterns. The approach weighs the benefits and drawbacks of antipsychotic combinations, considers special dosing considerations for older patients, and explores ketamine options following initial treatment failure. This strategy prioritizes matching adjunctive therapy to each patient's specific clinical profile.

When standard antidepressant medications fail to produce adequate relief, clinicians face complex decisions about next steps. This guidance framework helps mental health professionals evaluate which supplementary treatments might work best for individual patients, taking into account factors like age, previous medication responses, and specific symptom patterns. The recommendations examine various medication classes and their potential combinations, recognizing that what succeeds for one person may not suit another.

Emerging treatment options like ketamine represent newer possibilities for those who haven't benefited from conventional approaches. Dosing adjustments become particularly important in older adults, whose bodies process medications differently and who often take multiple prescriptions simultaneously. By systematizing how clinicians select add-on therapies, this approach aims to reduce the trial-and-error period patients often experience during treatment refinement.